Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 13/2020

Open Access 01-12-2020 | Pancreatic Cancer | ASO Author Reflections

ASO Author Reflections: Can Utilization of Cancer Registry Data Contribute to Solving the Lack of Evidence for Older Pancreatic Cancer Patients?

Authors: J. V. Groen, MD, C. J. H. van de Velde, MD, PhD, E. Bastiaannet, PhD, J. S. D. Mieog, MD, PhD

Published in: Annals of Surgical Oncology | Issue 13/2020

Login to get access

Excerpt

Pancreatic cancer has a poor prognosis with a 5-year survival of approximately 7%.1 Only patients with stage I–II (localized disease) have a chance of long-term survival after resection. Recently, some advances were made in patients with localized disease who were treated with neoadjuvant chemoradiation therapy2 or adjuvant FOLFIRINOX3. Unfortunately, the median age of patients included in these randomized controlled trials (63–67) are not representative for the general pancreatic cancer population.4 Older patients are often not included in clinical trials, leading to a knowledge gap in treating older patients. The international European Registration of Cancer Care (EURECCA) project is a research committee supported by the European Society of Surgical Oncology. The aim of EURECCA is to utilize cancer registry data to compare and improve treatment strategies.5 …
Literature
1.
Lepage C, Capocaccia R, Hackl M, et al. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5. Eur J Cancer. 2015; 51(15):2169–78.CrossRefPubMed
2.
3.
Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018; 379(25):2395–406.CrossRefPubMed
4.
Huang L, Jansen L, Balavarca Y, et al. Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003–2014: a large international population-based study. Int J Cancer. 2018; 143(12):3227–39.CrossRefPubMed
5.
Evrard S, van de Velde C, Noordhoek I, et al. European society of surgical oncology’s strategy for clinical research: paving the way for a culture of research in cancer surgery. Eur J Surg Oncol. 2019; 45(9):1515–9.CrossRefPubMed
6.
7.
Huttner FJ, Capdeville L, Pianka F, et al. Systematic review of the quantity and quality of randomized clinical trials in pancreatic surgery. Br J Surg. 2019; 106(1):23–31.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Can Utilization of Cancer Registry Data Contribute to Solving the Lack of Evidence for Older Pancreatic Cancer Patients?
Authors
J. V. Groen, MD
C. J. H. van de Velde, MD, PhD
E. Bastiaannet, PhD
J. S. D. Mieog, MD, PhD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08611-6

Other articles of this Issue 13/2020

Annals of Surgical Oncology 13/2020 Go to the issue

ASO Author Reflections

ASO Author Reflections: Role of Sentinel Lymph Node Biopsy in T1b Melanoma

Translational Research

Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies

ASO Author Reflections

ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers

ASO Author Reflections

ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?

Hepatobiliary Tumors

Technical Insights on Laparoscopic Left and Right Hepatectomy for Perihilar Cholangiocarcinoma

ASO Author Reflections

ASO Author Reflections: Characterizing the Peritoneal Immune Response to the Surgical and Thermal Trauma of Peritoneal Cytoreduction and HIPEC